Incyte (INCY) FCF Margin (2010 - 2026)

Incyte's (INCY) quarterly FCF Margin came in at 29.58% in Q2 2026, up 2747.0% YoY from 1.04% in Q2 2025, and up 4.83% on a QoQ basis from 28.22% in Q1 2026.

Incyte (INCY) FCF Margin (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of FCF Margin data on file, last reported at 29.58% in Q2 2026.

  • Quarterly FCF Margin rose 2747.0% year-over-year to 29.58% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 33.0% (up 1210.0% YoY) and the FY2025 annual result came in at 26.35%, up 2048.0% from the prior year.
  • FCF Margin climbed to 29.58% in Q2 2026, from 28.22% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 39.87% in Q3 2025 to a low of 60.33% in Q2 2024.
  • A 5-year average of 18.47% and a median of 26.98% in 2022 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2024 — FCF Margin plunged 9167 bps — and 2025, when it jumped 6244 bps.
  • Tracing INCY's FCF Margin over 5 years: stood at 28.31% in 2022, then plunged by 49 bps to 14.35% in 2023, then jumped by 115 bps to 30.87% in 2024, then grew by 12 bps to 34.6% in 2025, then decreased by 15 bps to 29.58% in 2026.
  • The last three FCF Margin figures came in at 29.58% (Q2 2026), 28.22% (Q1 2026), and 34.6% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 13.35%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.68%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,594.17%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 70.82%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 22.62%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -22.35%
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 29.58%

Historic Data

Download Data
DateValue
Jun 30, 2026 29.58%
Mar 31, 2026 28.22%
Dec 31, 2025 34.60%
Sep 30, 2025 39.87%
Jun 30, 2025 2.11%
Mar 31, 2025 24.97%
Dec 31, 2024 30.87%
Sep 30, 2024 26.86%
Jun 30, 2024 -60.33%
Mar 31, 2024 23.76%
Dec 31, 2023 14.35%
Sep 30, 2023 14.89%
Jun 30, 2023 31.34%
Mar 31, 2023 -14.53%
Dec 31, 2022 28.31%
Sep 30, 2022 32.62%
Jun 30, 2022 17.82%
Mar 31, 2022 27.10%
Dec 31, 2021 9.37%
Sep 30, 2021 27.42%